Application-based market taxonomy clusters demand into general surgery, cardiovascular, gynaecology, orthopaedics, urology, and oncology, each shaping generator specifications and replacement cycles. General surgery remains the volume anchor, driven by laparoscopic cholecystectomies and colectomies; facilities here prioritise reliable cut/coag modes and seek 5โ7-year replacement cycles, locking in mid-tier ASPs. Cardiovascular applications push technical boundaries, requiring ultra-low voltage outputs to avoid pacemaker interference and enabling suppliers to charge 20โ30 % premiums. Gynaecology propels bipolar upgrade sales because fallopian-tube sealing efficacy directly impacts medico-legal risk. Orthopaedics, by contrast, favours high-power monopolar units for electrocautery of highly vascular bone beds, translating into heavier generators with > 400 W peak. Urology and oncology segments, though smaller, accelerate adoption of argon-enhanced coagulation to achieve surface ablation, underpinning software-rich, high-margin SKUs. Collectively, these applications calibrate the revenue mix, explaining why the Surgical Generators segmentation exhibits more procedure-driven volatility than capital-device peers.